Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 4/20 | 1.00 |
| ▸ | HTR1A | P08908 | 5/20 | 0.67 |
| ▸ | HTR3A | P46098 | 5/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | HTR7 | P34969 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HTR6 | P50406 | 4/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.53 |
| ▸ | HTR3B | O95264 | 1/20 | 0.53 |
| ▸ | NCF1 | P14598 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | HTR1D | P28221 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29699369 | 1.00 | ADRB1 (1.00) | ADRB1HTR1AHTR3ACYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL27850954 | 0.98 | ADRB1 (0.96) | ADRB1HTR1AHTR3ACYP1A2CYP2D6 | |
| Piperazine SCHEMBL27593403 | 0.98 | ADRB1 (0.96) | ADRB1HTR1AHTR3ACYP1A2CYP2D6 | |
| Iodide SCHEMBL11457680 | 0.98 | ADRB1 (0.96) | ADRB1HTR1AHTR3ACYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL1894847 | 0.98 | ADRB1 (0.96) | ADRB1HTR1AHTR3ACYP1A2CYP2D6 | |
| SCHEMBL9310335 | 0.93 | ADRB1 (0.87) | ADRB1HTR1AHTR3ACYP1A2CYP2D6 | |
| SCHEMBL7487422 | 0.90 | ADRB1 (0.81) | ADRB1HTR1AHTR3ACYP1A2CYP2D6 | |
| SCHEMBL27868178 | 0.90 | ADRB1 (0.81) | ADRB1HTR1AHTR3ACYP1A2CYP2D6 | |
| SCHEMBL11067105 | 0.86 | ADRB1 (0.74) | ADRB1ALDH1A1NPSR1TSHRMAPK1 | |
| SCHEMBL7979300 | 0.85 | ADRB1 (0.74) | ADRB1HTR1AHTR3ACYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 941 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250026696-A1 | Novel Humic Material and Method to Formulate the Same | MEYER MICHAEL J (US) | 2025-01-23 | — | — | US | claimed |
| US-20230078902-A1 | Novel Method to Formulate Humic Substances | MEYER MICHAEL J (US) | 2023-03-16 | — | — | US | claimed |
| WO-2023279162-A1 | METHODS OF TREATMENT AND INHIBITION | UNIVERSITY OF CANBERRA (AU) | 2023-01-12 | — | — | WO | claimed |
| US-11548833-B2 | Method to formulate humic substances | MEYER MICHAEL J (US) | 2023-01-10 | — | — | US | claimed |
| US-20200385320-A1 | Method to Formulate Humic Substances | MEYER MICHAEL J (US) | 2020-12-10 | — | — | US | claimed |
| US-10568852-B2 | Combination compositions and their use in methods for treating obesity and obesity-related disorders | HELMHOLTZ ZENTRUM MUNCHEN - DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) (DE) | 2020-02-25 | — | — | US | claimed |
| CN-104311519-B | Functional food factor preparation and its application with mucosal lesion protective effect | 山东理工大学 | 2018-12-18 | — | — | CN | claimed |
| US-20180147163-A1 | COMBINATION COMPOSITIONS AND THEIR USE IN METHODS FOR TREATING OBESITY AND OBESITY-RELATED DISORDERS | HELMHOLTZ ZENTRUM MUNCHEN - DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) (DE) | 2018-05-31 | — | — | US | claimed |
| EP-3297676-A2 | COMBINATION OF TRPM8-AGONIST AND NACHR-AGONIST FOR TREATMENT OF OBESITY AND RELATED DISORDERS AND FOR WEIGHT REDUCTION | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2018-03-28 | — | — | EP | claimed |
| US-20170348430-A1 | MICELAR DELIVERY SYSTEM BASED ON ENZYME-RESPONSIVE AMPHIPHILIC PEG-DENDRON HYBRID | RAMOT AT TEL AVIV UNlVERSITY LTD. (IL) | 2017-12-07 | — | — | US | claimed |
| WO-2005016902-A1 | N-PHENYL-PIPERAZINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT2C RECEPTOR ASSOCIATED DISEASES | ARENA PHARMACEUTICALS, INC. (US) | 2005-02-24 | — | — | WO | claimed |
| JP-2004523588-A | — | — | 2004-08-05 | — | — | JP | claimed |
| US-20040132737-A1 | Nicotinic receptor agonists for the treatment of inflammatory diseases | UNIVERSITE LAVAL (CA) | 2004-07-08 | — | — | US | claimed |
| CN-1498108-A | Nicotinic receptor agonists for treatment of inflammatory diseases | �Ϻ���ͨ��ѧ | 2004-05-19 | — | — | CN | claimed |
| EP-1370264-A2 | NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Université Laval (CA) | 2003-12-17 | — | — | EP | claimed |
| WO-2002076434-A2 | NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | UNIVERSITE LAVAL (CA) | 2002-10-03 | — | — | WO | claimed |
| WO-2002059093-A1 | METHODS AND COMPOSITIONS FOR BINDING NUCLEIC ACID MOLECULES | GENESPAN CORPORATION (US) | 2002-08-01 | — | — | WO | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0615855-B1 | Recording sheets containing pyridinium and/or piperazinum compounds | XEROX CORP (US) | 1997-05-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10568852-B2 | Combination compositions and their use in methods for treating obesity and obesity-related disorders | FABP4, LIPC, GPR119 | ADRB1 668/4885HTR1A 1418/4885HTR3A 872/4885 |
| US-20180147163-A1 | COMBINATION COMPOSITIONS AND THEIR USE IN METHODS FOR TREATING OBESITY AND OBESITY-RELATED DISORDERS | FABP4, LIPC, GPR119 | ADRB1 668/4885HTR1A 1418/4885HTR3A 872/4885 |
| US-20170348430-A1 | MICELAR DELIVERY SYSTEM BASED ON ENZYME-RESPONSIVE AMPHIPHILIC PEG-DENDRON HYBRID | KIT, JMJD7, LIPA | ADRB1 3908/4885HTR1A 4157/4885HTR3A 3694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.